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+e epoxy fatty acid cis-12,13-epoxy-oleic acid, which acts as a DNA adduct, may be generated during long-term storage of many
seed oils, including those used in cooking, with frying oils and fried foods being a major source in the modern human diet.
Removal of this epoxy fatty acid from the locus of the N-formyl peptide receptors was associated with recovery from cogwheel
rigidity and akinesia as well as with improvement in vibration sense and olfactory perception.
1. Introduction
ADNA adduct is the covalent binding of a substance to DNA.
+e e5ect would depend on the position of the adduct on the
genome. At a gene location, expression of the gene may be
suppressed. On the promoter region of a gene, overexpression
is a possibility.
We present the 7rst case to be published of how removal
of an epoxy-fatty acid from the locus of the N-formyl peptide
receptors was associated with recovery from cogwheel rigidity
and akinesia as well as with improvement in vibration sense
and olfactory perception.
2. Case Report
A 51-year-old man presented with a two- to three-month
history of episodes of akinesia a5ecting his hands. It was
noted that his employment entailed regular and frequent
;ights, both long haul and short haul. +e history was
otherwise unremarkable.
Physical examination revealed cogwheel rigidity in the
upper limbs and impaired vibration sense which was absent
in the lower limbs, reduced rostrally to the level of the
anterior superior iliac spine. He was positive on both the
Unterberger test and Romberg’s test. Important negative
neurological signs were no evidence of abnormality of gait,
no tremor, no nystagmus, and no pain. Clinically, his long-
term memory appeared to be excellent. +e clinical exam-
ination was otherwise unremarkable.
Routine blood tests were insigni7cant. Investigation
for DNA adducts by analysis of genomic DNA from leu-
cocytes by gas-liquid chromatography showed the presence
of epoxy-oleic acid, which was localised to the N-formyl
peptide receptors (FPRs) using DNA microarrays. Other
investigations were carried out to exclude other possible
causes of the patient’s symptomatology; these proved neg-
ative and included testing for gonorrhoea, hepatitis B core
antibodies, hepatitis B surface antigen, hepatitis C anti-
bodies, HTLV-1, IgG and IgM antibodies to syphilis, and
antibodies to chlamydia species, as well as the HIV duo
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(HIV-1 and HIV-2 p24 antigen) and Venereal Disease
Research Laboratory (VDRL) tests.
Treatment was given in the form of supportive and
detoxi7cation nutrients, including glutathione, alpha-lipoic
acid, methylcobalamin and phosphatidylcholine, and reg-
ular high-temperature Iratherm® sessions. A repeat DNA
adduct investigation a year later proved negative. Supportive
nutritional treatment continued, and the patient was
assessed, a year later, for olfactory and gustatory function
and then again four months later. During this four-month
period, his score on the University of Pennsylvania Smell
Identi7cation Test [1] rose from 37/40 (a normal healthy
score is 35/40) to 38/40. Similarly, his score on the SniKn’
Sticks identi7cation at higher concentration test showed an
increase from 11/12 (normal) to the maximum score of 12/12
(above normal). Meanwhile, the patient became free of the
cogwheel rigidity and akinesia, while sensory vibration
impairment became limited to the left lower limb.
3. Discussion
Epoxy-fatty acids occur naturally in some plant seed oils,
but their toxic nature generally excludes those oils from
human food uses. +e cis-12,13-epoxy-oleic acid, also known
as vernolic acid, considered in this paper is present in
the seed oils of Vernonia anthelmintica and Vernonia gal-
amensis. In the latter case, it can account for as much as
60 percent of the total fatty acids. Small amounts of both
hydroxyl and epoxy fatty acids can be generated during long-
term storage of many seed oils, including oils used for
culinary purposes; frying oils and fried foods are the major
source of cis-12,13-epoxy-oleic acid in the human diet [2].
+is includes heated olive and sun;ower oils [3]. Epoxy-fatty
acids have been shown to be absorbed by healthy women [4].
+e means by which an epoxy-fatty acid can adduct to
genomic DNA has been explored in detail [5–7]. It is well
established that DNA adduct formation with some poten-
tially dangerous chemical intermediates can be promoted by
epoxy-group molecules [8].
At the time of writing, three FPRs are known; FPR1,
FPR2, and FPR3 are located in close proximity at 19q13.3.
While most members of the G-protein-coupled FPR family
are now known to be expressed by murine vomeronasal
sensory neurons [9], the above case report suggests that FPRs
may also have a role in early Parkinson’s disease. Indeed, the
amyloid-beta peptide Aβ42 has been shown to be an agonist
for FPR-like-1 (FPRL1); FPRL1 is strongly expressed by in-
;ammatory cells in7ltrating neuritic plaques in postmortem
Alzheimer cerebral tissue and so may be involved in the
cerebral in;ammatory processes associated with this form of
dementia [10].
As this report is based on a single case, there are clearly
limitations. A much larger study needs to be carried out in
order to ascertain the extent of the association of DNA
adducts with the neurological symptomology described
above. +e conclusions which may be drawn regarding the
eKcacy of the described treatment for the DNA adducts are
also limited by the fact that neither the patient nor his
doctors were blinded to the nature of his treatment and the
fact that there was no control group which received placebo
treatment.
+is case highlights the clinical value of checking for
and removing DNA adducts and calls attention to the
need for further research into the possible roles of FPRs in
neurodegenerative diseases.
4. Conclusion
In conclusion, this case report demonstrates that the
presence of DNA adducts should be considered in cases
of neurological presentations involving movement and/or
perceptual disorders when no other causes can be found.
Furthermore, the presence of such DNA adducts need not





FPR: N-formyl peptide receptor
HIV: Human immunode7ciency virus
HTLV-1: Human T-lymphotropic virus 1
IgG: Immunoglobulin G
IgM: Immunoglobulin M
VDRL: Venereal Disease Research Laboratory.
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